The Clasado team will be attending Probiota Americas 2023 to provide an opportunity for health and nutrition brands to explore the benefits of the class-leading prebiotic ingredient, Bimuno® GOS.

The conference will take place in Chicago, IL, USA, during the 14th to the 16th of June 2023. Probiota Americas brings together experts, industry professionals, and thought leaders in the field of probiotics and prebiotics, with a view to identifying the future of the industry.

During Probiota Americas, Clasado will be represented by Per Rehné, CEO, and Dr. Frederic Narbel, VP of Sales B2B. The Clasado team is eager to engage with attendees and discuss the latest advancements and insights in the field of prebiotics.

Don’t miss out – contact us today to arrange a meeting with our team at Probiota Americas 2023.

As a leading innovator in gut microbiome modulation, Clasado uses strong scientific backing to underline and amplify the power of prebiotics to enhance overall well-being.

With its multi award-winning galactooligosaccharide, Bimuno GOS, Clasado supplies its prebiotic ingredient to formulators and distributors around the world. Studies behind Bimuno GOS show significant positive impacts on digestive and gastrointestinal health, immune function, and beyond.

Per Rehné, CEO at Clasado, says: “Probiota Americas is one of the world’s premier microbiome-based conferences. It’s a fantastic opportunity to bring scientific expertise and industry knowledge together and use that to power the nutraceutical sector forwards. It’s a must-attend event for fostering discussion and driving innovation, and we’ll be in attendance to share insight from the prebiotic viewpoint. We look forward to engaging with formulators from around the world and sharing our latest scientific research and understanding of the potential of prebiotics.”

Clasado Biosciences invites all attendees of Probiota Americas to arrange a meeting with our team to explore the power of prebiotics and discuss potential collaborations. Click here to contact our team.